Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like Dinkle introduces series of printed circuit board (PCB) interface modules March 23, 2018 Nissan’s Door-Durability Robot Slams 14,000 Doors Per Day November 22, 2017 Taiwan’s Machine Tool Industry: An Inside Look November 28, 2017